A rare systemic etiology of heart failure and liver dysfunction.
amyloidosis
hepatic dysfunction
infiltrative cardiomyopathy
restrictive cardiomyopathy
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
16
03
2019
revised:
11
04
2019
accepted:
10
05
2019
entrez:
31
7
2019
pubmed:
31
7
2019
medline:
31
7
2019
Statut:
epublish
Résumé
Systemic amyloidosis is a rare condition that can manifest with cardiomyopathy, hepatic dysfunction, and renal disease. Diagnosis is often missed and/or delayed due to chronic multi-system involvement and indeterminate signs and symptoms. Treatment generally involves systemic therapy and autologous stem-cell transplantation.
Identifiants
pubmed: 31360486
doi: 10.1002/ccr3.2229
pii: CCR32229
pmc: PMC6637331
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1355-1357Déclaration de conflit d'intérêts
None declared.
Références
Circulation. 2005 Sep 27;112(13):2047-60
pubmed: 16186440
Blood. 2012 May 10;119(19):4391-4
pubmed: 22331188
Blood Adv. 2018 May 22;2(10):1046-1053
pubmed: 29748430
J Am Heart Assoc. 2012 Apr;1(2):e000364
pubmed: 23130126
Clin J Am Soc Nephrol. 2006 Nov;1(6):1331-41
pubmed: 17699366
QJM. 1998 Feb;91(2):141-57
pubmed: 9578896
J Cardiovasc Electrophysiol. 2013 Jul;24(7):793-8
pubmed: 23489983
Am J Cardiol. 2005 Feb 15;95(4):535-7
pubmed: 15695149
Clin Case Rep. 2019 Jun 03;7(7):1355-1357
pubmed: 31360486